Cargando…
Effect of methylprednisolone in severe and critical COVID-19: Analysis of 102 cases
BACKGROUND: The coronavirus disease 2019 (COVID-19) outbreak has brought great challenges to public health. Aggravation of COVID-19 is closely related to the secondary systemic inflammatory response. Glucocorticoids are used to control severe diseases caused by the cytokine storm, owing to their ant...
Autores principales: | Zhu, Hong-Ming, Li, Yan, Li, Bang-Yi, Yang, Shuang, Peng, Ding, Yang, Xiaojiao, Sun, Xue-Lian, Zhang, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723720/ https://www.ncbi.nlm.nih.gov/pubmed/33344594 http://dx.doi.org/10.12998/wjcc.v8.i23.5952 |
Ejemplares similares
-
Predictive value of serum cystatin C for risk of mortality in severe and critically ill patients with COVID-19
por: Li, Yan, et al.
Publicado: (2020) -
Study on the characteristics of intestinal motility of constipation in patients with Parkinson's disease
por: Zhang, Mei, et al.
Publicado: (2021) -
Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients
por: Zeng, Jia, et al.
Publicado: (2020) -
Comparison of demographic features and laboratory parameters between COVID-19 deceased patients and surviving severe and critically ill cases
por: Wang, Lei, et al.
Publicado: (2022) -
Clinical features and risk factors of severely and critically ill patients with COVID-19
por: Chu, Xin, et al.
Publicado: (2022)